Share: Facebook Twitter LinkedIn
Activity Provided By:

Society of Surgical Oncology

Multi-Modality Management of Stage IV Melanoma in the Era of Immunotherapy

Access Activity

Overview / Abstract:

Target Audience

This activity is intended for all surgeons and other health care professionals who are involved in the treatment of patients with melanoma.
Program Overview

Recent clinical trials suggest new options for neoadjuvant and adjuvant treatments for advanced melanoma. Surgical oncologists need to become familiar with these data to provide optimal treatment to their patients. This webinar is based on the SSO 2019 session.
Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize the mechanisms of action and toxicities of novel immunotherapeutic agents for metastatic melanoma
Integrate novel immunotherapeutic agents for metastatic melanoma in combination with surgery
Identify new agents likely to be approved for use in metastatic melanoma

Expiration

Jun 18, 2020

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Online

Credits / Hours

1.0

Accreditation

ACCME, ABS

Presenters / Authors / Faculty

Genvieve Boland, MD, PhD (Speaker)

Weill Cornelll Medicine
Mark Faries, MD (Speaker)

Cedars-Sinai Medical Center
Omid Hamid, MD (Speaker)

The Angeles Clinic and Research Institute

Activity Specialities / Related Topics

Dermatology, Oncology / Cancer / Radiation Therapy, Surgery

Sponsors / Supporters / Grant Providers

Merck, Amgen and Bristol-Myers-Squibb.

Keywords / Search Terms

Relias LLC melanoma, cancer, skin Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map